...
首页> 外文期刊>Digestive and liver disease: official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver >Ferric carboxymaltose treatment for iron deficiency anemia in children with inflammatory bowel disease: Efficacy and risk of hypophosphatemia
【24h】

Ferric carboxymaltose treatment for iron deficiency anemia in children with inflammatory bowel disease: Efficacy and risk of hypophosphatemia

机译:炎症性肠病患儿的缺铁性贫血的铁杂种含铁症:次磷血症的疗效和风险

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Although intravenous ferric carboxymaltose (FCM) is effective in treating iron deficiency anemia (IDA) in paediatric inflammatory bowel disease (pIBD), no data are available on its post-infusion related risks.
机译:背景:尽管静脉注射羧麦芽糖铁(FCM)对治疗小儿炎症性肠病(pIBD)中的缺铁性贫血(IDA)有效,但尚无关于其输注后相关风险的数据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号